Omada Health (NASDAQ:OMDA) CEO Sells 14,960 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 14,960 shares of the company’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $17.36, for a total value of $259,705.60. Following the completion of the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at $7,149,906.96. The trade was a 3.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Omada Health Stock Performance

NASDAQ OMDA traded up $0.41 during trading hours on Thursday, hitting $17.66. 788,759 shares of the company’s stock were exchanged, compared to its average volume of 1,205,677. The business’s 50 day moving average is $15.63 and its 200-day moving average is $14.79. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The firm has a market capitalization of $1.05 billion and a P/E ratio of -65.41.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million during the quarter. As a group, equities research analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on OMDA. Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Morgan Stanley decreased their price target on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a report on Friday, March 6th. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a report on Thursday, June 4th. Finally, Wells Fargo & Company increased their target price on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Omada Health has an average rating of “Moderate Buy” and an average price target of $22.91.

Institutional Investors Weigh In On Omada Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Raymond James Financial Inc. purchased a new stake in shares of Omada Health during the 2nd quarter valued at about $32,000. Bellevue Group AG lifted its position in Omada Health by 0.7% during the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock worth $5,567,000 after acquiring an additional 1,791 shares in the last quarter. Quarry LP purchased a new position in Omada Health in the 4th quarter worth approximately $29,000. Barclays PLC grew its position in Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after acquiring an additional 1,888 shares in the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new stake in Omada Health in the fourth quarter valued at approximately $32,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.